Cell Signaling Technology

Atg5 (D5G3) Rabbit Monoclonal Antibody

#9980 · western blot · $161,351

67

Evidence Score · Well-Established

Used by 281 independent labs across 304 papers. How we score this →

100

Citing papers

5.7k

Combined citations

Supplier page Find this product

Research areas

Autophagy in Disease and Therapy12 Neuroinflammation and Neurodegeneration Mechanisms9 Neuropeptides and Animal Physiology9 Pain Mechanisms and Treatments8 Alzheimer's disease research and treatments8 MicroRNA in disease regulation8 Neuroscience and Neuropharmacology Research6 PI3K/AKT/mTOR signaling in cancer6

Papers citing this product

1

Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology

Journal of Clinical Investigation·2004·464 cit.·DOI

2

Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology

Journal of Clinical Investigation·2004·436 cit.·DOI

3

Nucleoporin NUP153 Phenylalanine-Glycine Motifs Engage a Common Binding Pocket within the HIV-1 Capsid Protein to Mediate Lentiviral Infectivity

PLoS Pathogens·2013·294 cit.·DOI

4

Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity

Leukemia·2018·247 cit.·DOI

5

Pluripotent stem cell-derived model of the post-implantation human embryo

Nature·2023·220 cit.·DOI

6

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

Blood·2019·187 cit.·DOI

7

Nicotinamide Blocks Proliferation and Induces Apoptosis of Chronic Lymphocytic Leukemia Cells through Activation of the p53/miR-34a/SIRT1 Tumor Suppressor Network

Cancer Research·2011·165 cit.·DOI

8

Corticotropin-Releasing Factor Receptors Differentially Regulate Stress-Induced Tau Phosphorylation

Journal of Neuroscience·2007·146 cit.·DOI

9

The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy

PLoS ONE·2015·123 cit.·DOI

10

Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers

American Journal of Hematology·2018·120 cit.·DOI

Similar products

Product	Vendor	Evidence	Price	Papers
Atg5 AntibodyRabbit	Cell Signaling Technology	67	$317	100
Atg5 (D5F5U) Rabbit Monoclonal AntibodyRabbit	Cell Signaling Technology	67	$149,348	100

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.